First human test for new 'Double-Target' antibody begins
Knowledge-focused
Not yet recruiting
This is a first-in-human study to check the safety and side effects of a new antibody drug called HB2198 in healthy people. About 32 healthy adults will receive a single dose of the drug or a placebo. The main goal is to see how well the drug is tolerated and how it moves through…
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC